Hims & Hers (NYSE: HIMS) has been on a wild journey over the past year as GLP-1s drive both big gains and big losses for the ...

Hims & Hers Health (HIMS) stock gained after Citi upgraded the company, while agilon health (AGL) stock slipped after its downgrade. Read more here.

Fintel reports that on January 10, 2025, Citigroup downgraded their outlook for Hims & Hers Health (NYSE:HIMS) from Neutral ...

Citi downgraded Hims & Hers to Sell from Neutral with a price target of $25, up from $24. The firm thinks the market is overvaluing the ...

Hims & Hers reported impressive third-quarter results in November, with earnings of 32 cents per share, far exceeding analyst ...

You can actually stave them off with one very simple solution, and that means kissing "Possible Spam" (without any legitimate name, of course) goodbye. And who hasn't wanted to do that in their ...

Three unlikely winners of 2024 can lead the way in the year ahead. Some of the hottest stocks of 2024 may surprise you. A few ...

They say she will remain the legitimate president until fresh elections are held. The confrontation comes amid a month of protests sparked by Georgian Dream’s suspension of EU accession talks until ...

"We have only one legitimate president, and this is Salome Zourabichvili," she said. Georgian Dream got almost 54% of the vote in October's election, according to official results. Local and ...

They say she will remain the legitimate president until fresh elections are held. The confrontation comes amid a month of protests sparked by Georgian Dream’s suspension of EU accession talks ...

said in a defiant speech to supporters outside the presidential palace that she was leaving the residence but remained the legitimate officeholder.